Stockscreener 앱 받기
3.34
9.24%
-0.34
Agenus Inc 주식(AGEN)의 최신 뉴스
Agenus (AGEN) Q1 2025 Earnings Call Transcript - AOL.com
Agenus Forms Major Strategic Collaboration with Zydus Lifesciences - TipRanks
Agenus Announces the Closing of $141M Strategic Collaboration with Zydus Group - Oncodaily
Institution Moves: Will BHRPRD announce a stock splitPortfolio Risk Report & Weekly Return Optimization Plans - baoquankhu1.vn
Agenus and Zydus complete $141m BOT+BAL immunotherapy collaboration deal - Pharmaceutical Technology
Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness - 뉴스와이어
Agenus closes strategic collaboration with Zydus Lifesciences By Investing.com - Investing.com Nigeria
Zydus LifeSciences Acquires Biologics Manufacturing Facilities from Agenus - Contract Pharma
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences - BioPharm International
Agenus Falls After $141 Million Zydus Deal Closes - marketscreener.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Zydus Completes Agenus Biologics Facilities Acquisition And Launches U.S. CDMO Unit - Pulse 2.0
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S. - StreetInsider
New Zylidac Bio sites help secure U.S. biologic drug supply chains - Stock Titan
AGENAgenus Latest Stock News & Market Updates - Stock Titan
Agenus closes strategic collaboration with Zydus Lifesciences - Investing.com
Zydus Lifesciences Completes Agenus Acquisition, Establishes Zylidac Bio LLC for US Biologics Manufacturing - scanx.trade
Cancer combo shows 42% 2yr survival as $141M immunotherapy deal closes - Stock Titan
Agenus appoints CEO Garo Armen as interim CFO and names new accounting officer - Investing.com Nigeria
Agenus appoints CEO Garo Armen as interim CFO and names new accounting officer By Investing.com - Investing.com South Africa
Agenus Consolidates Financial Leadership With Interim CFO Appointment - TipRanks
Agenus Inc. Appoints Austin Charette as Principal Accounting Officer, Effective January 8, 2026 - marketscreener.com
France Expands National AAC Access for Agenus' Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas - 뉴스와이어
Agenus (AGEN) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
About Us - FinancialContent
AGEN Stock Price, Forecast & Analysis | AGENUS INC (NASDAQ:AGEN) - Chartmill
Agenus Inc. (NASDAQ:AGEN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Why Agenus Inc. stock is a must watch in 20252025 Geopolitical Influence & Reliable Price Breakout Alerts - Улправда
What risks investors should watch in Agenus Inc. stockEarnings Overview Summary & Daily Stock Trend Reports - Улправда
Is Agenus Inc. stock attractive for income investorsNew Guidance & Low Risk Entry Point Guides - Улправда
Will Agenus Inc. stock sustain high P E ratiosJuly 2025 Setups & Community Verified Swing Trade Signals - Улправда
Agenus amends Ligand agreement, modifies warrant holder rights - TipRanks
How geopolitical tensions affect Agenus Inc. stockMarket Trend Review & Weekly Watchlist for Consistent Profits - Улправда
Agenus unit, MiNK surges after peer-reviewed data for lead drug - MSN
Is Agenus Inc. stock a good choice for value investorsEarnings Forecast Updates & Outstanding Growth Stocks - ulpravda.ru
What valuation multiples suggest for Agenus Inc. stockHead and Shoulders Patterns & Superior Portfolio Investment - ulpravda.ru
Aug Summary: Is Agenus Inc stock attractive for income investorsWeekly Risk Report & Stepwise Entry and Exit Trade Signals - Bộ Nội Vụ
Agenus (AGEN) Q4 2024 Earnings Call Transcript - AOL.com
Agenus (AGEN) Q3 2024 Earnings Call Transcript - The Motley Fool
Is Agenus Inc a good long term investmentRSI Overbought/Oversold & Learn the Basics of Investing in 5 Days - earlytimes.in
H.C. Wainwright Upgrades Agenus (AGEN) Stock to Buy - MSN
Agenus (AGEN) CEO Garo Armen Takes 4,942 Shares as Salary Payment - Stock Titan
Short Interest in Agenus Inc. (NASDAQ:AGEN) Rises By 56.5% - MarketBeat
Agenus publishes C-800-01 trial data in The Journal for Immunotherapy of Cancer - MSN
Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC - BioSpace
Agenus reports positive results for cancer immunotherapy in ovarian cancer By Investing.com - Investing.com Nigeria
Agenus Inc AJ8 Stock Analysis and ForecastVolume Analysis Techniques & High Return Investment Ideas - earlytimes.in
Botensilimab + Balstilimab in Refractory MSS mCRC: Insights from an ESMO AnalysisAgenus - Oncodaily
Agenus publishes C-800-01 trial data in The Journal for ImmunoTherapy of Cancer - TipRanks
Agenus reports positive results for cancer immunotherapy in ovarian cancer - Investing.com India
4.73%
0.92%
자본화:
|
볼륨(24시간):